Quarterly Dividends, Invitations to Conference Calls, Completion of Acquisitions, and Certifications for Healthcare Products - Research Report on Covidien, Bard, Mindray, CareFusion, and DENTSPLY

NEW YORK, July 23, 2013 /PRNewswire/ --

Today, Investors' Reports announced new research reports highlighting Covidien plc (NYSE: COV), C.R. Bard, Inc. (NYSE: BCR), Mindray Medical International Limited (NYSE: MR), CareFusion Corporation (NYSE: CFN), and DENTSPLY International Inc. (NASDAQ: XRAY). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Covidien plc Research Report

On July 17, 2013, Covidien plc (Covidien) announced that the Company's Board of Directors has declared a quarterly cash dividend of $0.26 per ordinary share. The dividend is payable on August 15, 2013 to shareholders of record as of the close of business on July 30, 2013. Covidien previously announced that it will report its Q3 FY 2013 results on August 1, 2013 before trading begins, and hold a conference call for investors at 8:30 a.m. ET on the same day. The Full Research Report on Covidien plc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-07-18/COV]

--

C.R. Bard, Inc. Research Report

On July 9, 2013, C.R. Bard, Inc. (Bard) announced that it will host a conference call on July 23, 2013 at 5:00 p.m. EDT, to discuss the Company's Q2 2013 operating results, as well as to provide financial guidance for Q3 2013. Bard informed that the earnings press release will be issued on the same day, after the market closes. In Q1 2013, Bard reported a 1% YoY increase in net sales, amounting to $740.3 million. Q1 2013 net income was $90.7 million and diluted EPS was $1.08, a decrease of 35% YoY and 33% YoY, respectively. The Full Research Report on C.R. Bard, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-07-18/BCR]

--

Mindray Medical International Limited Research Report

On July 17, 2013, Mindray Medical International Limited (Mindray) announced the completion of its acquisition of ZONARE Medical Systems, Inc. (ZONARE), pursuant to the terms of the previously announced definitive agreement entered into on June 12, 2013. Under the agreement, Mindray acquired ZONARE for a total purchase price of $101.7 million in cash, as adjusted for working capital at the closing date. Mindray expects that the combined business will benefit from ZONARE's strong innovative R&D capability and direct sales and service network in the high-end ultrasound market together with Mindray's efficient engineering, extensive distribution channels, and broad production platforms. The Full Research Report on Mindray Medical International Limited - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-07-18/MR]

--

CareFusion Corporation Research Report

On July 16, 2013, CareFusion Corporation (CareFusion) announced that it was one of the first groups of health IT products providers that has received certification under a new healthcare certification program launched by IHE USA and ICSA Labs. The Company informed that under the certification program, the products met rigorous testing requirements for security and interoperability. CareFusion also stated that the certification builds on specifications of the Federal Office of the National Coordinator for Health IT, giving purchasers of health IT products independent third-party verification that products are suitable for health data exchange and function as intended. The certification program will expand by utilizing virtual testing events in fall of 2013, leading up to the 2014 IHE North American Connectathon to be held from January 27 to January 31, 2014 in Chicago. The Full Research Report on CareFusion Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-07-19/CFN]

--

DENTSPLY International Inc. Research Report

On July 15, 2013, DENTSPLY International Inc. (DENTSPLY) announced that it will release its Q2 2013 earnings results on August 1, 2013 at 7:00 a.m. ET. Following the press release, the Company will host a conference call with a live webcast to discuss the financial results. In its Q1 2013 earnings results release, Bret Wise, Chairman and CEO of DENTSPLY commented on the Company's full-year 2013 outlook, "Looking forward, we believe that we have opportunities to accelerate growth in both sales and earnings as the year progresses. Given the current market environment and currency exchange rates, we are revising our expectations for adjusted earnings per share for 2013 to a range of $2.33 to $2.43." The Full Research Report on DENTSPLY International Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-07-19/XRAY]

----

EDITOR NOTES:

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

SOURCE Investors' Reports